SCHEMBL312745

SCHEMBL312745

CC1CCN[C@@H]1C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4588183 1.00
SCHEMBL882973 1.00
SCHEMBL2034574 1.00
SCHEMBL5207176 1.00
SCHEMBL312744 1.00
SCHEMBL6079315 1.00
SCHEMBL2182805 1.00
SCHEMBL312743 1.00
SCHEMBL7558402 0.98 SLC1A2 (0.56)
SCHEMBL7558398 0.98 SLC1A2 (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2552 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114085272-A Isaridin cyclic depsipeptide derivative and preparation method and application thereof 中山大学 2022-02-25 CN claimed
US-11203622-B2 MASP isoforms as inhibitors of complement activation OMEROS CORPORATION (US) 2021-12-21 US claimed
EP-2688578-B1 MIA (MELANOMA INHIBITORY ACTIVITY) INHIBITORS FOR PREVENTING AND CURING VITILIGO BORDIGNON MATTEO (IT) 2019-03-27 EP claimed
US-8912146-B2 Derivatives of APF and methods of use UNIVERSITY OF MARYLAND, BALTIMORE (US) 2014-12-16 US claimed
CN-103930122-A MIA (melanoma inhibitory activity protein) inhibitor for detecting, preventing and treating leukoderma BORDIGNON MATTEO 2014-07-16 CN claimed
US-20140155371-A1 MULTICOMPONENT CRYSTALLINE SYSTEM OF EZETIMIBE AND PROLINE BASF SE (DE) 2014-06-05 US claimed
EP-2688578-A2 MIA (MELANOMA INHIBITORY ACTIVITY) INHIBITORS FOR DETECTING, PREVENTING AND CURING VITILIGO Bordignon, Matteo (IT) 2014-01-29 EP claimed
US-20140004130-A1 MIA (Melanoma Inhibitory Activity) Inhibitors for Detecting, Preventing and Curing Vitiligo BORDIGNON MATTEO (IT) 2014-01-02 US claimed
WO-2013014604-A1 MULTICOMPONENT CRYSTALLINE SYSTEM OF EZETIMIBE AND PROLINE BASF SE (DE) 2013-01-31 WO claimed
WO-2012127352-A2 MIA (MELANOMA INHIBITORY ACTIVITY) INHIBITORS FOR DETECTING, PREVENTING AND CURING VITILIGO BORDIGNON MATTEO (IT) 2012-09-27 WO claimed
US-8148493-B2 Method for inhibiting “melanoma inhibitory activity” MIA ANTISENSE PHARMA GMBH (DE) 2012-04-03 US claimed
WO-2011085393-A1 STABLE INSULIN FORMULATIONS AND METHODS OF MAKING AND USING THEREOF GENECOPOEIA, INC. (US) 2011-07-14 WO claimed
US-20100273705-A1 Method for inhibiting \"Melanoma Inhibitory Activity\" MIA ANTISENSE PHARMA GMBH. 2010-10-28 US claimed
US-20060128607-A1 Method for inhibiting \"melanoma inhibitory activity\" mia ANTISENSE PHARMA GMBH (DE) 2006-06-15 US claimed
EP-1472279-A1 A METHOD FOR INHIBITING \"MELANOMA INHIBITORY ACTIVITY\" MIA Antisense Pharma GmbH (DE) 2004-11-03 EP claimed
WO-2003064457-A1 A METHOD FOR INHIBITING 'MELANOMA INHIBITORY ACTIVITY' MIA ANTISENSE PHARMA GMBH (DE) 2003-08-07 WO claimed
US-6084065-A FOR AGRICULTURAL USE ISAGRO SPA (IT) 2000-07-04 US claimed
US-5658885-A OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1997-08-19 US claimed
EP-0718280-A2 Derivatives of beta-aminopropionic acid with a fungicidal activity ISAGRO RICERCA S.r.l. (IT) 1996-06-26 EP claimed
EP-0652229-A2 Oligopeptides with fungicidal activity ISAGRO S.p.A. (IT) 1995-05-10 EP claimed